Economic Costs of Diabetes in the U.S. in 2017 - PubMed (original) (raw)
Economic Costs of Diabetes in the U.S. in 2017
American Diabetes Association. Diabetes Care. 2018 May.
Abstract
Objective: This study updates previous estimates of the economic burden of diagnosed diabetes and quantifies the increased health resource use and lost productivity associated with diabetes in 2017.
Research design and methods: We use a prevalence-based approach that combines the demographics of the U.S. population in 2017 with diabetes prevalence, epidemiological data, health care cost, and economic data into a Cost of Diabetes Model. Health resource use and associated medical costs are analyzed by age, sex, race/ethnicity, insurance coverage, medical condition, and health service category. Data sources include national surveys, Medicare standard analytical files, and one of the largest claims databases for the commercially insured population in the U.S.
Results: The total estimated cost of diagnosed diabetes in 2017 is 327billion,including327 billion, including 327billion,including237 billion in direct medical costs and 90billioninreducedproductivity.Forthecostcategoriesanalyzed,careforpeoplewithdiagnoseddiabetesaccountsfor1in4healthcaredollarsintheU.S.,andmorethanhalfofthatexpenditureisdirectlyattributabletodiabetes.Peoplewithdiagnoseddiabetesincuraveragemedicalexpendituresof∼90 billion in reduced productivity. For the cost categories analyzed, care for people with diagnosed diabetes accounts for 1 in 4 health care dollars in the U.S., and more than half of that expenditure is directly attributable to diabetes. People with diagnosed diabetes incur average medical expenditures of ∼90billioninreducedproductivity.Forthecostcategoriesanalyzed,careforpeoplewithdiagnoseddiabetesaccountsfor1in4healthcaredollarsintheU.S.,andmorethanhalfofthatexpenditureisdirectlyattributabletodiabetes.Peoplewithdiagnoseddiabetesincuraveragemedicalexpendituresof∼16,750 per year, of which ∼$9,600 is attributed to diabetes. People with diagnosed diabetes, on average, have medical expenditures ∼2.3 times higher than what expenditures would be in the absence of diabetes. Indirect costs include increased absenteeism ($3.3 billion) and reduced productivity while at work ($26.9 billion) for the employed population, reduced productivity for those not in the labor force ($2.3 billion), inability to work because of disease-related disability ($37.5 billion), and lost productivity due to 277,000 premature deaths attributed to diabetes ($19.9 billion).
Conclusions: After adjusting for inflation, economic costs of diabetes increased by 26% from 2012 to 2017 due to the increased prevalence of diabetes and the increased cost per person with diabetes. The growth in diabetes prevalence and medical costs is primarily among the population aged 65 years and older, contributing to a growing economic cost to the Medicare program. The estimates in this article highlight the substantial financial burden that diabetes imposes on society, in addition to intangible costs from pain and suffering, resources from care provided by nonpaid caregivers, and costs associated with undiagnosed diabetes.
© 2018 by the American Diabetes Association.
Figures
Figure 1
Percent of medical condition-specific expenditures associated with diabetes. Data sources: NIS (2014), CMS MDS (2013), NAMCS (2013–2015), NHAMCS (2012–2014), MEPS (2011–2015), NHHCS (2007), NHIS (2014–2016), OptumInsight dNHI (2015), and Medicare 5% SAFs (2014). See
Supplementary Appendix 2
for diagnosis codes for each category of medical condition.
Figure 2
Total direct costs of diabetes, 2007–2017.
Figure 3
Total indirect costs of diabetes, 2007–2017.
Figure 4
Total economic cost of diabetes, 2007–2017.
Figure 5
Average cost of diabetes, 2007–2017 (in 2017 dollars).
Similar articles
- Economic costs of diabetes in the U.S. In 2007.
American Diabetes Association. American Diabetes Association. Diabetes Care. 2008 Mar;31(3):596-615. doi: 10.2337/dc08-9017. Diabetes Care. 2008. PMID: 18308683 Review. - Economic costs of diabetes in the U.S. in 2012.
American Diabetes Association. American Diabetes Association. Diabetes Care. 2013 Apr;36(4):1033-46. doi: 10.2337/dc12-2625. Epub 2013 Mar 6. Diabetes Care. 2013. PMID: 23468086 Free PMC article. - Economic costs of diabetes in the US in 2002.
Hogan P, Dall T, Nikolov P; American Diabetes Association. Hogan P, et al. Diabetes Care. 2003 Mar;26(3):917-32. doi: 10.2337/diacare.26.3.917. Diabetes Care. 2003. PMID: 12610059 - Economic Costs of Diabetes in the U.S. in 2022.
Parker ED, Lin J, Mahoney T, Ume N, Yang G, Gabbay RA, ElSayed NA, Bannuru RR. Parker ED, et al. Diabetes Care. 2024 Jan 1;47(1):26-43. doi: 10.2337/dci23-0085. Diabetes Care. 2024. PMID: 37909353 Review. - Economic consequences of diabetes mellitus in the U.S. in 1997. American Diabetes Association.
[No authors listed] [No authors listed] Diabetes Care. 1998 Feb;21(2):296-309. doi: 10.2337/diacare.21.2.296. Diabetes Care. 1998. PMID: 9539999
Cited by
- Developing a Physical Activity Program for Mothers and Their Children at Risk for Diabetes.
Andreae SJ, Lindberg A, Casey T, Pickett KA. Andreae SJ, et al. Health Serv Res Manag Epidemiol. 2024 Sep 23;11:23333928241284178. doi: 10.1177/23333928241284178. eCollection 2024 Jan-Dec. Health Serv Res Manag Epidemiol. 2024. PMID: 39328808 Free PMC article. - Effects of an instructional WhatsApp group on self-care and HbA1c among female patients with Type 2 diabetes mellitus.
Alhazmy RS, Khalil AH, Almutary H. Alhazmy RS, et al. PLoS One. 2024 Sep 18;19(9):e0305845. doi: 10.1371/journal.pone.0305845. eCollection 2024. PLoS One. 2024. PMID: 39292676 Free PMC article. - Making the Most of Familismo to Curb the Diabetes Epidemic: Early Evidence of Success Delivering the Same Intervention to Latinas at Risk for and With Diabetes.
Joachim-Célestin M, Montgomery SB. Joachim-Célestin M, et al. Clin Med Insights Endocrinol Diabetes. 2024 Sep 14;17:11795514241274696. doi: 10.1177/11795514241274696. eCollection 2024. Clin Med Insights Endocrinol Diabetes. 2024. PMID: 39291260 Free PMC article. - Association between sleep regularity and arterial stiffness among middle-age adults in Southwestern China.
Shang YH, Liang DQ, Song XL, Feng X, Mao GY, Yang TT, Wang ZY, Wang JH. Shang YH, et al. BMC Public Health. 2024 Sep 17;24(1):2530. doi: 10.1186/s12889-024-20054-2. BMC Public Health. 2024. PMID: 39289652 Free PMC article. - Engineered IRES-mediated promoter-free insulin-producing cells reverse hyperglycemia.
Li Y, Ahamed Younis D, He C, Ni C, Liu R, Zhou Y, Sun Z, Lin H, Xiao Z, Sun B. Li Y, et al. Front Endocrinol (Lausanne). 2024 Aug 30;15:1439351. doi: 10.3389/fendo.2024.1439351. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39279997 Free PMC article.
References
- Centers for Disease Control and Prevention. National Diabetes Statistics Report [Internet], 2017. Available from https://www.cdc.gov/diabetes/data/statistics/statistics-report.html. Accessed 30 November 2017.
- American Diabetes Association Economic costs of diabetes in the U.S. in 2007. Diabetes Care 2008;31:596–615 - PubMed
- U.S. Bureau of Labor Statistics. Consumer Price Index (CPI) databases [Internet]. Available from https://www.bls.gov/cpi/data.htm. Accessed 30 November 2017.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical